Advanced Therapies Week 2022 | Optimizing CGT manufacturing processes with digitalization

Kwok Pang, COO, Autolomous, London, UK, discusses the relevance of the concept of Industry 4.0 within the cell and gene therapy (CGT) space, highlighting the advantages of process analytical technologies (PAT). To scale up manufacturing in the CGT industry, it is critical to understand the data in order to optimize manufacturing processes. However, many technologies in the CGT space have limited data exchange capabilities. PATs enable monitoring the data in real-time, which allows us to have a better understanding of the process. This interview took place at Advanced Therapies Week 2022.